ArticleOncoTargets and therapy2026
Sintilimab-Induced Sequential Multi-System Severe Immune-Related Adverse Events in an Elderly Patient with Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review.
Xi Xia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.